$89.00
The 10mg extended-protocol format of OVA’s FDA-validated visceral fat peptide — designed for women running full 16-week protocols or maintaining tesamorelin as an ongoing component of their metabolic health stack.
3-5 business days
SSL encrypted
Tesamorelin’s clinical evidence base — FDA approval, randomized controlled trials, and consistent visceral fat reduction data — makes it one of the most research-supported peptides in the GH secretagogue category. The 10mg vial supports a full 16-week protocol at 1mg daily dosing, making it the economically sensible choice for women committed to a complete treatment course.
Extended tesamorelin protocols (beyond 12 weeks) show continued VAT reduction and additional metabolic benefits including improved triglyceride levels, reduced ectopic fat in the liver, and preserved lean mass. For perimenopausal women who are simultaneously managing visceral fat accumulation, insulin resistance, and body composition changes from declining GH, tesamorelin addresses the hormonal fat distribution component specifically and effectively.
Female-calibrated dosing: 1mg subcutaneously daily for 16 weeks. The 10mg vial covers a complete protocol with room for minor dose adjustments. Evening dosing aligns with natural GH pulse timing. Monitor fasting glucose if running alongside a GLP-1 agonist.
Storage: Store lyophilized powder below -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.
| Dosage | 10mg |
|---|---|
| Format | Injectable Vial |
| Cycle Length | 12–16 weeks |
| Storage | Freeze until use. Refrigerate after reconstitution. Use within 30 days. |
Reviews
There are no reviews yet.